Citations

Showing 10 of 108083 citations.

SARCOPENIA, TELOMERE LENGTH AND MORTALITY: NHANES 1999–2002
MacKenzie, Todd A. , Rippberger, P., Bartels, Stephen J. , Batsis, John A. , Emeny, Rebecca T. , López-Jiménez, Francisco

Mayo Clinic

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 204-204

10.1093/geroni/igx004.773 Get It

CELLULAR SENESCENCE DRIVES FIBROTIC PULMONARY DISEASE
White, Thomas A. , Iijima, Koji, Mazula, Daniel L., Passos, JF, Kirkland, James L. , Schafer, Marissa , Kita, Hirohito , LeBrasseur, Nathan K.

Mayo Clinic

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 135-135

10.1093/geroni/igx004.547 Get It

Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works
Segraves, J. , Cartin‐Ceba, Rodrigo , Leise, Michael D. , Krowka, Michael J. , Segraves, Justin M

Mayo Clinic

Hepatology Research | July 1, 2017 | Volume: 48 | Issue: 3 | Pages: No page available

10.1111/hepr.12930 | PMID 28667665 Get It

AimPortopulmonary hypertension is a serious complication of portal hypertension that can lead to right heart failure and death. To our knowledge, an association between portopulmonary hypertension and prior splenectomy has not been described previously. The goals of this study were to describe the frequency of splenectomy in portopulmonary hypertension and compare selected parameters between portopulmonary hypertension subgroups.MethodsThis is a retrospective analysis of patients diagnosed with portopulmonary hypertension between 1 January 1988 and 30 June 2015 at Mayo Clinic (Rochester, MN, USA). We compared age, sex, right ventricle systolic pressure by echocardiography, and right heart catheterization measurements/calculations among subgroups of portopulmonary hypertension patients with splenectomy and/or autoimmune liver disease (autoimmune hepatitis/primary biliary cirrhosis/primary sclerosing cholangitis).ResultsThe cohort consisted of 141 patients, of whom 8 (6%) had a history of splenectomy prior to the development of portopulmonary hypertension. Twenty‐seven (19%) portopulmonary hypertension patients had autoimmune liver disease, and 5 of 8 (62.5%) splenectomized portopulmonary hypertension patients had autoimmune liver disease. No significant difference was noted in right heart catheterization measurements/calculations between splenectomized and non‐splenectomized portopulmonary hypertension patients. Right ventricle systolic pressure by echocardiography was significantly higher in those splenectomized.ConclusionsPrior history of splenectomy in portopulmonary hypertension was 6% in this cohort. The combination of autoimmune liver disease and splenectomy in portopulmonary hypertension was not uncommon. History of splenectomy in patients with portal hypertension and/or autoimmune liver disease may have clinical implications.
EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
Mehner, Christine , Oberg, Ann L. , Goergen, Krista M., Kalli, Kimberly R., Goode, Ellen L. , Keeney, Gary L., Jatoi, Aminah , Radisky, Evette S. , Radisky, Derek C. , Maurer, Matthew J. , Nassar, Aziza , Radisky, Evette S

Mayo Clinic

Genes & Cancer | July 1, 2017 | Volume: 8 | Issue: 5-6 | Pages: 589-599

10.18632/genesandcancer.142 | PMID 28740577 Get It

KEYNOTE: WHAT COULD COME FROM UNDERSTANDING THE BIOLOGY OF AGING?
Kirkland, James L. , Rooij, Sophia E. de , Kuipers, Folkert

Mayo Clinic

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 1081-1082

10.1093/geroni/igx004.3966 Get It

PROOF-OF-CONCEPT CLINICAL TRIALS OF INTERVENTIONS THAT TARGET FUNDAMENTAL AGING PROCESSES
Kirkland, James L.

Mayo Clinic

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 1082-1082

10.1093/geroni/igx004.3967 Get It

The Utility of Sentinel Node Biopsy for Sinonasal Melanoma
Oldenburg, Michael , Oldenburg, Michael S, Price, Daniel L.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | June 30, 2017 | Volume: 78 | Issue: 05 | Pages: 425-429

10.1055/s-0037-1603960 | PMID 28875122 Get It

Objective Report two positive sentinel node biopsies for sinonasal melanoma. Design Retrospective review. Setting Academic tertiary care center. Participants Patients who underwent sentinel node biopsy for sinonasal melanoma between November 1, 2014 and November 1, 2015. Main Outcome Measures Clinical course. Results Two patients were identified. Patient 1 (83M) presented with a sinonasal melanoma anterior to the left inferior turbinate and was clinically N0 neck. Lymphoscintigraphy revealed two sentinel nodes in the ipsilateral and three in the contralateral cervical basins. The left level I sentinel node was positive for melanoma and lymphadenectomy showed no additional metastases.Patient 2 (71F) presented after incomplete resection of a sinonasal melanoma of the left posterior maxillary sinus wall and was clinically N0 neck. Lymphoscintigraphy with single-photon emission computed tomography (SPECT/CT) localization revealed one sentinel node in the parapharyngeal space and another in the ipsilateral cervical basin. Metastatic melanoma was found in both nodes and completion lymphadenectomy was negative for additional disease.Both patients developed distant metastasis in less than 1 year after surgical resection but responded well to adjuvant immunomodulatory chemotherapeutic agents. Conclusion Sentinel node biopsy for sinonasal melanoma can provide crucial clinical evidence of regional metastasis prior to overt clinical signs and symptoms. This intraoperative tool has the potential to improve detection of regional metastasis and improve long-term outcomes of this aggressive malignancy.
PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry
Jabbour, Tony El , Sheehan, Christine E., Geiersbach, Katherine B. , Boguniewicz, Ann, Ainechi, Sanaz, Bronner, Mary P. , Jones, David , Lee, Hwajeong , Ross, Jeffrey S , Affolter, Kajsa E. , Lee, Hwajeong , Geiersbach, Katherine

Mayo Clinic

Journal of Clinical Pathology | June 30, 2017 | Volume: 71 | Issue: 1 | Pages: 46-51

10.1136/jclinpath-2017-204525 | PMID 28667193 Get It

Aims Routine application of PD-L1 immunohistochemistry (IHC) in colorectal cancer (CRC) is limited due to lack of standardized scoring criteria, antibody clones, and intratumoral staining heterogeneity. We assessed PD-L1 protein expression on full face CRC tissue sections and applied two algorithms based on the published clinical trials that support the recent FDA approval for immune checkpoint inhibitors (ICPI) therapy in non-small cell lung cancer (NSCLC). Methods PD-L1/CD274 IHC (Roche/Ventana, clone SP142) was performed on representative tumour blocks from 52 mismatch repair-deficient (MMR-D) and 52 MMR-proficient (MMR-P) CRCs. Membranous PD-L1 expression was scored for the tumour cell (TC) and tumour-infiltrating immune cell (IC) components. PD-L1 positivity status was determined based on the published NSCLC clinical trials that utilized the Ventana SP142 assay. Hybrid capture-based comprehensive genomic profiling (CGP) was performed on a separate set of 2268 clinically advanced CRCs and the frequency of PD-L1/PD-L2 amplification was determined. Results PD-L1 expression in the TC and IC correlated with MMR-D (p=0.013, p<0.0001), T stage (p=0.036, p=0.0036) and clinical stage (p=0.022, p=0.0037). PD-L1 positivity status correlated with MMR-D by two algorithms. Five of 2268 (<1%) advansced CRCs demonstrated amplification of either the PD-L1 or PD-L2 genes by CGP. Conclusions PD-L1 expression in TC and IC is associated with advanced stage and MMR-D. PD-L1 positivity status by the published algorithm is associated with MMR-D. PD-L1 amplification is extremely uncommon in CRC. Evaluation of whole tissue section and incorporation of IC staining enhance the sensitivity to screen patients who may benefit from ICPI therapy.
THE LINK BETWEEN DEPRESSION AND FRAILTY AMONG OLDER VETERANS FROM A VA GERIATRIC CLINIC
Kim, Hui Ji , Canaday, David H. , Burant, Christopher J. , Higgins, Paul , Hornick, Thomas R.

Mayo Clinic

Innovation in Aging | June 30, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 818-818

10.1093/geroni/igx004.2952 Get It